Table 1.
Distribution of Anayzed Populations by Ancestry Groups, Sex, Human Immunodeficiency Virus Infection Status, and Hepatitis C Virus Clearance or Persistence
| HCV Infection, No. of Participants (% HIV Positive) | |||||||
|---|---|---|---|---|---|---|---|
| Male Participants | Female Participants | Total | |||||
| Study Participants by Ancestry Group | Participants, Total (Male:Female), No. | HCV Persistence | HCV Clearance | HCV Persistence | Clearance | HCV Clearance | HCV Persistence |
| Extended HCV Multi-Cohort Study | |||||||
| African ancestry | 1869 (1245:624) | 1054 (35.1) | 191 (34.0) | 475 (42.3) | 149 (57.8) | 1529 (37.3): | 340 (44.4) |
| European ancestry | 1736 (1192:544) | 703 (17.1) | 489 (14.6) | 332 (10.5) | 212 (15.1) | 1035 (14.9) | 701 (14.7) |
| Multiancestry Hispanic | 486 (288:198) | 197 (27.9) | 91 (14.2) | 116 (46.5) | 82 (56.1) | 313 (34.8) | 173 (34.1) |
| African Ancestry Group 2 | |||||||
| African ancestry | 332 (178:154) | 130 (8.5) | 48 (22.9) | 97 (11.3) | 57 (14.0) | 227 (9.7) | 105 (18.1) |
| Total | 4423 (2903:1520) | 2084 (26.7) | 819 (19.5) | 1020 (29.5) | 500 (34.4) | 3104 (26.7) | 1319 (19.5) |
Abbreviations: HCV, hepatitis C virus; HIV, human immunodeficiency virus.